§ Same category · GLP-1 / metabolic peptides
CagriSema vs Tirzepatide
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
CagriSema
0
vendors tracked
Tirzepatide
3
vendors tracked
from $1.45/mg
CagriSema
Amylin + GLP-1 combination research stack
No current listings at 5mg.
Tirzepatide
Dual GLP-1/GIP agonist
B
Operational$39.99
$4.00/mg
Out of stock◎ Best $/mg
Watch
$99.99
$10.00/mg
In stock▲ 150.0% vs best
| Vendor | Grade | Risk | Price | $/mg | Trend | Stock | |
|---|---|---|---|---|---|---|---|
| Welli Labs US | B | Operational | $39.99 ◎ Best $/mg | $4.00 | Out | Buy with code → | |
| Felix Chemical Supply US | B- | Watch | $99.99 ▲ 150.0% | $10.00 | In stock | Visit → |
Sort:
Last crawl 2026-11-12Sort:
2026-11-12About CagriSema
A combination of cagrilintide and semaglutide in late-stage clinical development for obesity. Research-compound version mirrors the clinical dose ratio.
About Tirzepatide
A once-weekly dual GIP and GLP-1 receptor agonist studied for type-2 diabetes and obesity. Approved clinically in many jurisdictions; research-compound form is widely distributed.